SIREN : 900520909
GALVAMED is a French company founded 4 years ago, specialized in the sector Fonds de placement et entités financières similaires. Based in NIMES (30900), this company of category PME shows in 2024 a net income positive of 95 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Revenue | N/C | N/C | N/C | N/C |
| Net income | 94 833 € | 193 923 € | 142 395 € | -5 165 € |
| EBITDA | N/C | N/C | N/C | N/C |
| Net margin | N/C | N/C | N/C | N/C |
In 2024, GALVAMED generates positive net income of 95 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
94 833 €
The debt ratio (= Financial debt / Equity x 100) stands at 54%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 65%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
54.079%
64.902%
In 2024, the debt ratio of GALVAMED (54.08) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of GALVAMED (64.9%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Indicative estimate only : the number of comparable transactions in this sector is limited (26 transactions). This range of 266 354€ to 1 837 730€ is provided for information purposes only and requires in-depth analysis to be confirmed.
This estimate is based on the analysis of 26 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare GALVAMED with other companies in the same sector:
Voir toutes les statistiques du secteur Fonds de placement et entités financières similaires
The revenue of GALVAMED is not publicly disclosed (confidential accounts filed with INPI).
Yes, GALVAMED generated a net profit of 95 k€ in 2024.
The headquarters of GALVAMED is located in NIMES (30900), in the department Gard.
The tax return of GALVAMED is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
GALVAMED operates in the sector Fonds de placement et entités financières similaires (NAF code 64.30Z). See the 'Sector positioning' section above to compare the company with its competitors.